InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the complete record of transactions filed by Barclay Alec, Officier. Director active across 1 company, notably T2 Biosystems, Inc.. Aggregated, 4 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €6k. Activity tracked since 8 April 2022. The latest transaction was filed on 8 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Alec Barclay is the Chief Operations Officer at T2 Biosystems, Inc. He oversees the company's operations and contributes to growth strategy. His expertise is essential for the success of the organization.